Protea Biosciences, Inc. along with its affiliates, filed a motion for joint administration of their Chapter 11 bankruptcy cases in the US Bankruptcy Court on December 1, 2017. As per the motion, the debtor seeks the joint administration of the cases of its affiliate, Protea Biosciences Group, Inc. with its own case for administrative and procedural purposes. Protea Biosciences, Inc. has been proposed as the lead debtor.